Compare Becton Dickinson and Co (BDX) vs Norwegian Cruise Line Holdings Ltd (NCLH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Becton Dickinson and Co vs Norwegian Cruise Line Holdings Ltd — how do they compare? Becton Dickinson and Co trades at $180.54 (market cap $49.41B), while Norwegian Cruise Line Holdings Ltd trades at $19.09 (market cap $8.59B). The key difference: Becton Dickinson and Co is far larger — about 5.8× Norwegian Cruise Line Holdings Ltd's market cap, and Becton Dickinson and Co pays a 2.32% dividend while Norwegian Cruise Line Holdings Ltd pays none. Which is the better fit depends on your goals.
| BDX | NCLH | |
|---|---|---|
Market Cap | $49.41B | $8.59B |
Sector | Health | Consumer Cyclical |
52-Week High | $185.39 | $26.94 |
52-Week Low | $138.62 | $14.79 |
Enterprise Value | $65.51B | $23.40B |
Dividend Yield | 2.32% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BDX trades at $179.63, up 1.57% with a bullish technical outlook supported by moving averages. The company reported strong Q3 2026 earnings, beating estimates with $3.23 EPS versus $3.14 expected, and raised full-year guidance. Revenue growth remains steady at 4.4% FX-neutral, though margins face pressure from tariffs. Analysts maintain a mixed consensus with 47% buy ratings and a $183 price target, suggesting modest upside from current levels.
The stock presents a balanced opportunity with solid fundamentals and dividend stability, but faces headwinds from margin compression and competitive pressures. Near-term catalysts include continued execution on growth initiatives, while risks include tariff impacts and healthcare regulatory changes. The current valuation at 31.39 P/E appears fair given growth prospects.
NCLH trades at $18.55, down 3.64% today, amid a bearish technical signal. The company reported Q2 2026 EPS of $0.48, beating estimates, but faces headwinds from high fuel costs and soft demand. Revenue growth is steady, with 2025 revenue at $9.83B, and profitability metrics like a 7.49% net income margin show resilience. Analyst consensus is bullish with a $20.73 price target, though recent news highlights execution risks and macroeconomic pressures.
The outlook is mixed: strong fundamentals and analyst support suggest upside potential, but near-term volatility from cost pressures and travel demand uncertainty poses risks. Investors should weigh the attractive valuation against operational challenges in the cruise industry.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Becton Dickinson and Co
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.
Read more on BDX →About Norwegian Cruise Line Holdings Ltd
Norwegian Cruise Line is the world's third-largest cruise company by berths (at more than 62,000), operating 29 ships across three brands (Norwegian, Oceania, and Regent Seven Seas), offering both freestyle and luxury cruising. The company has redeployed its entire fleet as of May 2022. With eight passenger vessels on order among its brands through 2027 (representing 20,000 incremental berths), Norwegian is increasing capacity faster than its peers, expanding its brand globally. Norwegian sailed to around 500 global destinations before the pandemic.
Read more on NCLH →
